Expression of HNF-1 beta in cervical carcinomas: an immunohistochemical study of 155 cases

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10295099" target="_blank" >RIV/00216208:11110/15:10295099 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/15:10295099

Result on the web

<a href="http://dx.doi.org/10.1186/s13000-015-0245-9" target="_blank" >http://dx.doi.org/10.1186/s13000-015-0245-9</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1186/s13000-015-0245-9" target="_blank" >10.1186/s13000-015-0245-9</a>

Result language

angličtina

Original language name

Expression of HNF-1 beta in cervical carcinomas: an immunohistochemical study of 155 cases

Original language description

Methods: We analyzed HNF-1 beta expression in 155 cervical carcinomas (including 56 adenocarcinomas, 85 squamous cell carcinomas and 14 undifferentiated carcinomas). Expression of HNF-1 beta was correlated with the expression of other markers including estrogen receptors, progesterone receptors, CEA, p63, p40, p16, and D2-40. Results: Adenocarcinomas showed expression of HNF-1 beta in 42/56 cases (75%), CEA in 48/56 cases (85.7%), p63 in 4/56 cases (7.2%), p40 in 2/56 cases (3.6%), estrogen receptors in9/56 cases (16.1%), progesterone receptors in 5/56 cases (8.9%), p16 in 56/56 (100%) cases, and D2-40 in 0/56 cases (0%). Squamous cell carcinomas showed expression of HNF-1 beta in 2/85 cases (2.35%), CEA in 77/85 cases (90.6%), p63 and p40 in 85/85 cases (100%), estrogen receptors in 9/85 cases (10.6%), progesterone receptors in 1/85 cases (1.2%), p16 in 84/85 cases (98.8%), and D2-40 in 45/84 cases (53.6%). Undifferentiated carcinomas showed expression of HNF-1 beta in 2/14 cases (14

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FP - Other medical fields

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Diagnostic Pathology

ISSN

1746-1596

e-ISSN

—

Volume of the periodical

10

Issue of the periodical within the volume

March

Country of publishing house

GB - UNITED KINGDOM

Number of pages

7

Pages from-to

—

UT code for WoS article

000354359400001

EID of the result in the Scopus database

2-s2.0-84929146238